{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:37:44Z","timestamp":1790811464712,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T00:00:00Z","timestamp":1415059200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0108994","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T18:55:58Z","timestamp":1415127358000},"page":"e108994","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["Inhibition of Kidney Proximal Tubular Glucose Reabsorption Does Not Prevent against Diabetic Nephropathy in Type 1 Diabetic eNOS Knockout Mice"],"prefix":"10.1371","volume":"9","author":[{"given":"Muralikrishna","family":"Gangadharan Komala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshini","family":"Mudaliar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Pegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Mather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Panchapakesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,11,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000324934","article-title":"Epidemiology of diabetic nephropathy","volume":"170","author":"AT Reutens","year":"2011","journal-title":"Contrib Nephrol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"RR Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/ndt\/gfr696","article-title":"Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial","volume":"27","author":"M Evans","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2011.861","article-title":"Temporal trends in the prevalence of diabetic kidney disease in the United States","volume":"305","author":"IH de Boer","year":"2011","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Ghosh RK, Ghosh SM, Chawla S, Jasdanwala SA (2011) SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes Mellitus. J Clin Pharmacol 0091270011400604 [pii] 10.1177\/0091270011400604 [doi].","DOI":"10.1177\/0091270011400604"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MNH.0b013e32833bec06","article-title":"Sodium-glucose transport: role in diabetes mellitus and potential clinical implications","volume":"19","author":"V Vallon","year":"2010","journal-title":"Current opinion in nephrology and hypertension"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Mather A, Pollock C (2011) Glucose handling by the kidney. Kidney international Supplement 10.1038\/ki.2010.509: S1\u20136.","DOI":"10.1038\/ki.2010.509"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrneph.2010.38","article-title":"Renal glucose transporters: novel targets for hyperglycemia management","volume":"6","author":"A Mather","year":"2010","journal-title":"Nature reviews Nephrology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/01.ASN.0000093460.24823.5B","article-title":"Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator","volume":"15","author":"FN Ziyadeh","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"F1388","DOI":"10.1152\/ajprenal.00055.2008","article-title":"Role of Kruppel-like factor 6 in transforming growth factor-beta1-induced epithelial-mesenchymal transition of proximal tubule cells","volume":"295","author":"J Holian","year":"2008","journal-title":"American journal of physiology Renal physiology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"F800","DOI":"10.1152\/ajprenal.00179.2004","article-title":"Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosis","volume":"288","author":"W Qi","year":"2005","journal-title":"American journal of physiology Renal physiology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1046\/j.1523-1755.1998.00916.x","article-title":"TGF-beta 1 dissociates human proximal tubule cell growth and Na(+)-H+ exchange activity","volume":"53","author":"DW Johnson","year":"1998","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1681\/ASN.2010111210","article-title":"Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy","volume":"23","author":"M Lin","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"F143","DOI":"10.1152\/ajprenal.00398.2012","article-title":"The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules","volume":"305","author":"H Mudaliar","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"F528","DOI":"10.1152\/ajprenal.00445.2003","article-title":"The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells","volume":"287","author":"U Panchapakesan","year":"2004","journal-title":"American journal of physiology Renal physiology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"F1153","DOI":"10.1152\/ajprenal.00097.2005","article-title":"PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose","volume":"289","author":"U Panchapakesan","year":"2005","journal-title":"American journal of physiology Renal physiology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00370446","article-title":"Proximal tubular cell sodium concentration in early diabetic nephropathy assessed by electron microprobe analysis","volume":"418","author":"CA Pollock","year":"1991","journal-title":"Pflugers Arch"},{"key":"ref18","first-page":"F946","article-title":"Tubular sodium handling and tubuloglomerular feedback in experimental diabetes mellitus","volume":"260","author":"CA Pollock","year":"1991","journal-title":"Am J Physiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"F1070","DOI":"10.1152\/ajprenal.00013.2006","article-title":"Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells","volume":"291","author":"W Qi","year":"2006","journal-title":"American journal of physiology Renal physiology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e54442","DOI":"10.1371\/journal.pone.0054442","article-title":"Effects of SGLT2 inhibition in human kidney proximal tubular cells\u2013renoprotection in diabetic nephropathy?","volume":"8","author":"U Panchapakesan","year":"2013","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1681\/ASN.2009070721","article-title":"Mouse models of diabetic nephropathy","volume":"20","author":"FC Brosius 3rd","year":"2009","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1097\/01.ASN.0000128219.65330.EA","article-title":"Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat","volume":"15","author":"C Maric","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/dom.12090","article-title":"Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease","volume":"15","author":"JF Yale","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Nagata T, Fukuzawa T, Takeda M, Fukazawa M, Mori T, et al.. (2013) Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function in db\/db mice. Br J Pharmacol 10.1111\/bph.12269.","DOI":"10.1111\/bph.12269"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1124\/jpet.113.203869","article-title":"Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats","volume":"345","author":"N Kojima","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/ki.1996.372","article-title":"Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells","volume":"50","author":"PW Anderson","year":"1996","journal-title":"Kidney Int"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000093632","article-title":"Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications","volume":"26","author":"PA Sarafidis","year":"2006","journal-title":"Am J Nephrol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"C348","DOI":"10.1152\/ajpcell.00115.2012","article-title":"Regulation of the human Na+-dependent glucose cotransporter hSGLT2","volume":"303","author":"C Ghezzi","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"F156","DOI":"10.1152\/ajprenal.00409.2012","article-title":"Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus","volume":"304","author":"V Vallon","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Vallon V, Gerasimova M, Rose M, Masuda T, Satriano J, et al.. (2013) SGLT2 Inhibitor Empagliflozin Reduces Renal Growth and Albuminuria in Proportion to Hyperglycemia and Prevents Glomerular Hyperfiltration in Diabetic Akita Mice. Am J Physiol Renal Physiol 10.1152\/ajprenal.00520.2013.","DOI":"10.1152\/ajprenal.00520.2013"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00467-011-1992-9","article-title":"Tubulointerstitial injury and the progression of chronic kidney disease","volume":"27","author":"KS Hodgkins","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"E117","DOI":"10.1152\/ajpendo.00439.2012","article-title":"Improved glycemic control in mice lacking Sglt1 and Sglt2","volume":"304","author":"DR Powell","year":"2013","journal-title":"American journal of physiology Endocrinology and metabolism"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/138920207780368187","article-title":"Functional properties and genomics of glucose transporters","volume":"8","author":"FQ Zhao","year":"2007","journal-title":"Curr Genomics"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0108994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T01:10:57Z","timestamp":1566004257000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0108994"}},"subtitle":[],"editor":[{"given":"Nick","family":"Ashton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,4]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0108994","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,4]]}}}